Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dogs of the Dow to Invest in. HSBC Turns More Bullish on Amgen (AMGN) into 2026 On December 8, HSBC lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $425 from$381. The firm also retained a Buy rating. The call came as part of the firm’s 2026 outlook for the pharma sector. HSBC sees the group in a strong position heading into 2026, “even more so if AI panic kicks in.” While its top picks lean toward “growth bucket ideas,” the firm noted that “f ...